These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 18071034

  • 1. Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
    Corvol JC, Anzouan-Kacou JB, Fauveau E, Bonnet AM, Lebrun-Vignes B, Girault C, Agid Y, Lechat P, Isnard R, Lacomblez L.
    Arch Neurol; 2007 Dec; 64(12):1721-6. PubMed ID: 18071034
    [Abstract] [Full Text] [Related]

  • 2. Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.
    Dewey RB, Reimold SC, O'Suilleabhain PE.
    Arch Neurol; 2007 Mar; 64(3):377-80. PubMed ID: 17353380
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Severe insuffiency of the aortic and tricuspidal valves associated with pergolide use].
    van Strater AC, Bax JJ, van Hilten JJ, Jukema JW.
    Ned Tijdschr Geneeskd; 2005 Apr 16; 149(16):891-4. PubMed ID: 15868996
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both.
    Ozer F, Tiras R, Cetin S, Ozturk O, Aydemir T, Ozben S, Meral H, Kizkin S, Bader H, Ozben B.
    J Clin Neurosci; 2009 Jan 16; 16(1):83-7. PubMed ID: 19014887
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Valvular heart disease and the use of dopamine agonists for Parkinson's disease.
    Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G.
    N Engl J Med; 2007 Jan 04; 356(1):39-46. PubMed ID: 17202454
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide.
    Chung EJ, Yoon WT, Kim JY, Lee WY.
    Mov Disord; 2006 Apr 04; 21(4):586-7. PubMed ID: 16482572
    [No Abstract] [Full Text] [Related]

  • 13. Valvular heart disease in patients taking pergolide.
    Waller EA, Kaplan J, Heckman MG.
    Mayo Clin Proc; 2005 Aug 04; 80(8):1016-20. PubMed ID: 16092580
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.
    Junghanns S, Fuhrmann JT, Simonis G, Oelwein C, Koch R, Strasser RH, Reichmann H, Storch A.
    Mov Disord; 2007 Jan 15; 22(2):234-8. PubMed ID: 17094087
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].
    van Laar T, Berendse H, Bloem BR, Boon AJ, van Hilten JJ, Hovestadt A, de Koning-Tijssen MA, Nijssen PC, Weber WE.
    Ned Tijdschr Geneeskd; 2009 Jan 17; 153(3):87-90. PubMed ID: 19235345
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J.
    Parkinsonism Relat Disord; 2005 Sep 17; 11(6):393-8. PubMed ID: 15993640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.